Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bumi Serpong Damai Tbk PT
OTC:BSPDY
|
ID |
|
Healthier Choices Management Corp
OTC:HCMC
|
US |
|
Asia Development Capital Co Ltd
TSE:9318
|
JP |
|
B
|
Basic Sanitation Company of the State of Sao Paulo SABESP
SWB:SAJA
|
BR |
|
G
|
Getty Copper Inc
XTSX:GTC
|
CA |
|
Chlitina Holding Ltd
TWSE:4137
|
TW |
|
Epiroc AB
STO:EPI A
|
SE |
|
Z
|
Zhongxin Fruit and Juice Ltd
SGX:5EG
|
SG |
Pharma Equity Group A/S
Note Receivable
Pharma Equity Group A/S
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Note Receivable
kr501k
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Note Receivable?
Note Receivable
501k
DKK
Based on the financial report for Jun 30, 2025, Pharma Equity Group A/S's Note Receivable amounts to 501k DKK.
What is Pharma Equity Group A/S's Note Receivable growth rate?
Note Receivable CAGR 5Y
-63%
Over the last year, the Note Receivable growth was -51%. The average annual Note Receivable growth rates for Pharma Equity Group A/S have been -80% over the past three years , -63% over the past five years .
